IQVIA (IQV) competitors & alternatives
Health Care · NYSE
IQVIA (IQV)'s top competitors and alternatives — its most similar public companies — include Charles River Laboratories (CRL), Tempus AI (TEM), GENERATE BIOMEDICINES INC (GENB), WHITEFIBER INC (WYFI), Certara, Inc. (CERT), Alphabet Inc. (Class A) (GOOGL), GENEDX HOLDINGS CORP CLASS A (WGS), Clarivate (CLVT), Intel (INTC), IBM (IBM), SHARONAI HOLDINGS INC CLASS A (SHAZ) and Revvity (RVTY). These are IQVIA's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top IQV competitors & alternatives
-
Charles River LaboratoriesCRLHealth Care
A global contract research organization providing non-clinical drug development services, research models, and manufacturing solutions across discovery, safety…
$218.70 (as of 2026-07-22) · market cap $10.6B
-
Tempus AITEMHealth Care
Tempus AI leverages genomic sequencing, clinical data aggregation, and machine learning to deliver precision oncology diagnostics and AI-powered treatment…
$46.96 (as of 2026-07-22) · market cap $8.4B
-
GENERATE BIOMEDICINES INCGENBHealth Care
Generate Biomedicines is a clinical-stage biotechnology company leveraging generative artificial intelligence to design novel, programmable protein…
$13.90 (as of 2026-07-22) · market cap $1.8B
-
WHITEFIBER INCWYFIInformation Technology
WhiteFiber is a leading AI infrastructure provider operating high-performance computing data centers and delivering cloud-based GPU services for enterprise AI…
$27.86 (as of 2026-07-22) · market cap $997M
-
Certara, Inc.CERTHealth Care
Certara utilizes proprietary biosimulation software and expert-led AI to help pharmaceutical companies optimize drug development and increase the probability…
$6.89 (as of 2026-07-22) · market cap $1.1B
-
Alphabet Inc. (Class A)GOOGLCommunication Services
A leader in the digital economy, Alphabet powers the world's information and advertising ecosystems while driving innovation in cloud computing and AI.
$342.09 (as of 2026-07-22) · market cap $4.24T
-
GENEDX HOLDINGS CORP CLASS AWGSHealth Care
GeneDx is a genomic intelligence platform using whole-genome sequencing and AI-powered interpretation to diagnose rare diseases, analyze cancers, and support…
$62.60 (as of 2026-07-22) · market cap $1.9B
-
ClarivateCLVTIndustrials
Clarivate provides the essential data, analytics, and insights that empower organizations to accelerate the pace of innovation and protect their intellectual…
$1.99 (as of 2026-07-22) · market cap $1.3B
-
IntelINTCInformation Technology
Intel is a global semiconductor giant transforming its business model to integrate advanced processor design with a large-scale foundry service for external…
$102.62 (as of 2026-07-22) · market cap $530.8B
-
IBMIBMInformation Technology
IBM delivers hybrid cloud platforms and AI-powered consulting services to help enterprises modernize infrastructure and accelerate digital transformation at…
$205.77 (as of 2026-07-22) · market cap $197.4B
-
SHARONAI HOLDINGS INC CLASS ASHAZInformation Technology
A purpose-built Australian neocloud operator providing sovereign AI and high-performance computing infrastructure powered by advanced NVIDIA GPUs for…
$70.49 (as of 2026-07-22) · market cap $2.5B
-
RevvityRVTYHealth Care
Revvity is a leading health science technology company providing integrated workflows and reagents spanning drug discovery, development, and diagnostic…
$110.54 (as of 2026-07-22) · market cap $12.3B
Not quite? Describe exactly what you want →
Peers are IQVIA's closest public companies by shared sub-industry, sector and business themes. See the full profile: IQVIA (IQV).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.